Immo Pharma Pas

Immo Pharma Pas has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €192,530 and a net result of -€14,718. Equity remains stable across the filed financial years (±1.8% per year). Its solvency ranks better than 90% of 397 sector peers (NACE 70, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).